Mei-Zahav, M.; Gendler, Y.; Bruckheimer, E.; Prais, D.; Birk, E.; Watad, M.; Goldschmidt, N.; Soudry, E.
Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial. J. Clin. Med. 2020, 9, 3130.
https://doi.org/10.3390/jcm9103130
AMA Style
Mei-Zahav M, Gendler Y, Bruckheimer E, Prais D, Birk E, Watad M, Goldschmidt N, Soudry E.
Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial. Journal of Clinical Medicine. 2020; 9(10):3130.
https://doi.org/10.3390/jcm9103130
Chicago/Turabian Style
Mei-Zahav, Meir, Yulia Gendler, Elchanan Bruckheimer, Dario Prais, Einat Birk, Muhamad Watad, Neta Goldschmidt, and Ethan Soudry.
2020. "Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial" Journal of Clinical Medicine 9, no. 10: 3130.
https://doi.org/10.3390/jcm9103130
APA Style
Mei-Zahav, M., Gendler, Y., Bruckheimer, E., Prais, D., Birk, E., Watad, M., Goldschmidt, N., & Soudry, E.
(2020). Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial. Journal of Clinical Medicine, 9(10), 3130.
https://doi.org/10.3390/jcm9103130